微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.49% | 31.34% | 100.37% | 18/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 2.74% | 37.69% | -40.69% | 26/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 4.62% | -65.37% | -31.35% | 58/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 6.73% | -30.4% | 61% | 34/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 4.18% | -35.39% | 110.05% | 40/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.99% | -37.62% | -85.08% | 47/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 13.34% | -8.38% | 37.95% | 10/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 9.67% | -10.46% | 49.46% | 19/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 6.47% | -8.1% | 102.82% | 20/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 3.19% | -4.2% | -78.09% | 23/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 14.56% | 16.11% | 34.81% | 14/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 10.8% | 21.08% | 53.41% | 25/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 7.04% | 33.33% | 111.41% | 25/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.33% | -0.6% | -73.44% | 36/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 12.54% | 6.27% | 40.58% | 52/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 8.92% | -4.29% | 68.94% | 62/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 5.28% | -19.27% | 57.61% | 67/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 3.35% | -2.9% | -71.61% | 48/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 11.8% | 147.38% | 26.61% | 72/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 9.32% | 137.76% | 42.51% | 65/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 6.54% | 253.51% | 89.57% | 62/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 3.45% | 439.06% | -27.67% | 47/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 4.77% | -69.62% | 21.68% | 109/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 3.92% | -68.05% | 111.89% | 75/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 1.85% | -73.65% | 189.06% | 95/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 0.64% | -81.61% | -95.92% | 63/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 15.7% | -10.23% | 27.95% | 53/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 12.27% | 2.25% | 74.79% | 23/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 7.02% | -1.82% | 101.72% | 27/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 3.48% | -6.2% | -80.1% | 16/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 17.49% | -8.14% | 45.75% | 40/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 12% | -7.76% | 67.83% | 16/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 7.15% | -9.72% | 92.72% | 19/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 3.71% | 1.64% | -80.51% | 18/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 19.04% | -9.68% | 46.35% | 32/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 13.01% | -14.97% | 64.27% | 12/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 7.92% | -20.64% | 116.99% | 19/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 3.65% | -31.26% | -82.69% | 11/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 21.08% | -6.39% | 37.78% | 20/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 15.3% | -3.77% | 53.31% | 6/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 9.98% | -3.57% | 87.95% | 11/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 5.31% | -1.3% | -76.42% | 3/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |